Tramazoline

Chemical formula: C₁₃H₁₇N₃  Molecular mass: 215.3 g/mol  PubChem compound: 5524

Active ingredient description

Tramazoline is an α-sympathomimetic agent with local action, which mainly causes vasoconstriction and therefore immediately reduces mucosal edema.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
R01AA09 Tramazoline R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AA Sympathomimetics, plain
Discover more medicines within R01AA09

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 1082-57-1
CAS Substance: 3715-90-0
DrugBank Drug: DB13064
PubChem Compound: 5524
RxNorm Ingredient: 38453
SNOMED-CT Concept: 420558000
Tramazoline (substance)
UNII Identifier: SLE31693IV
TRAMAZOLINE

Medicines

Tramazoline is an active ingredient of these brands:

Cyprus (CY)

Netherlands (NL)

Romania (RO)

Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈